A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

NCT06240351 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Frontal Fibrosing Alopecia

Interventions

DRUG: Baricitinib 4 MG Oral Tablet

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]